QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distrib...

Core News & Articles

NAYA Biosciences, Inc. ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough trea...

Core News & Articles

Maxim Group analyst Jason McCarthy upgrades NAYA Biosciences (NASDAQ:NAYA) from Hold to Buy and announces $2 price target.

Core News & Articles

Each Unit Consisting Of One Common Share And One Warrant; Warrants Exercisable Immediately With $0.87 Exercise Price, Expiring ...

Core News & Articles

  PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications• ...

Core News & Articles

NAYA Biosciences ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments...

Core News & Articles

NAYA Biosciences ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION